KEYNOTE-590: First-line (pembrolizumab, in combination with platinum and fluoropyrimidine-based chemotherapy) treatment of locally advanced unresectable or metastatic carcinoma of the oesophagus in adults whose tumours express PD-L1 with a CPS ≥10
Supporting documentation
Prescribing Information [External link]
By clicking the link above you will leave the MSD Connect website and be taken to the emc PI portal website.